日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Elranatamab治疗复发或难治性多发性骨髓瘤:MagnetisMM-3 II期试验结果

Lesokhin, Alexander M; Tomasson, Michael H; Arnulf, Bertrand; Bahlis, Nizar J; Miles Prince, H; Niesvizky, Ruben; Rodrίguez-Otero, Paula; Martinez-Lopez, Joaquin; Koehne, Guenther; Touzeau, Cyrille; Jethava, Yogesh; Quach, Hang; Depaus, Julien; Yokoyama, Hisayuki; Gabayan, Afshin Eli; Stevens, Don A; Nooka, Ajay K; Manier, Salomon; Raje, Noopur; Iida, Shinsuke; Raab, Marc-Steffen; Searle, Emma; Leip, Eric; Sullivan, Sharon T; Conte, Umberto; Elmeliegy, Mohamed; Czibere, Akos; Viqueira, Andrea; Mohty, Mohamad

Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin

肠内柠檬酸铁的吸收依赖于铁转运蛋白铁转运蛋白

Mark R Hanudel, Brian Czaya, Shirley Wong, Maxime Rappaport, Shweta Namjoshi, Kristine Chua, Grace Jung, Victoria Gabayan, Bo Qiao, Elizabeta Nemeth, Tomas Ganz

Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease

柠檬酸铁对慢性肾病小鼠模型的肾脏保护作用

Mark R Hanudel, Brian Czaya, Shirley Wong, Grace Jung, Kristine Chua, Bo Qiao, Victoria Gabayan, Tomas Ganz

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans

红细胞生成素对小鼠和人类成纤维细胞生长因子23的影响

Hanudel, Mark R; Eisenga, Michele F; Rappaport, Maxime; Chua, Kristine; Qiao, Bo; Jung, Grace; Gabayan, Victoria; Gales, Barbara; Ramos, Georgina; de Jong, Maarten A; van Zanden, Jelmer J; de Borst, Martin H; Bakker, Stephan J L; Nemeth, Elizabeta; Salusky, Isidro B; Gaillard, Carlo A J M; Ganz, Tomas

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors

JAK1抑制剂伊他替尼联合白蛋白紫杉醇和吉西他滨治疗晚期实体瘤的Ib/II期研究

Beatty, Gregory L; Shahda, Safi; Beck, Thaddeus; Uppal, Nikhil; Cohen, Steven J; Donehower, Ross; Gabayan, Afshin Eli; Assad, Albert; Switzky, Julie; Zhen, Huiling; Von Hoff, Daniel D

Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease

患有慢性肾脏病的小鼠和人类体内促红细胞生成素反应激素红细胞生成素的水平

Mark R Hanudel, Maxime Rappaport, Kristine Chua, Victoria Gabayan, Bo Qiao, Grace Jung, Isidro B Salusky, Tomas Ganz, Elizabeta Nemeth

A Risk Score to Predict Short-term Outcomes Following Emergency Department Discharge

用于预测急诊出院后短期预后的风险评分

Gabayan, Gelareh Z; Gould, Michael K; Weiss, Robert E; Chiu, Vicki Y; Sarkisian, Catherine A

Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice

在小鼠中,长期使用促红细胞生成素治疗并不产生血糖调节和血液学效应,而红细胞生成素并非必需。

Coffey, Richard; Sardo, Ugo; Kautz, Léon; Gabayan, Victoria; Nemeth, Elizabeta; Ganz, Tomas

Erythroferrone and matriptase-2 independently regulate hepcidin expression

红细胞生成素和膜蛋白酶-2独立调节铁调素的表达

Aschemeyer, Sharraya; Gabayan, Victoria; Ganz, Tomas; Nemeth, Elizabeta; Kautz, Léon

Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model

在小鼠模型中,血清铁调素升高会导致慢性肾脏病贫血。

Hanudel, Mark R; Rappaport, Maxime; Gabayan, Victoria; Jung, Grace; Salusky, Isidro B; Nemeth, Elizabeta; Ganz, Tomas; Zaritsky, Joshua